Listed

Employers Holdings, Inc.: Form 10-Q for the period ended Sep 30, 2025

Filed with the SEC on Oct 31, 2025 and accepted by EDGAR at Oct 31, 2025, 16:17 ET.

Share

Management's discussion and analysis

As filed, 52,298 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

You should read the following discussion and analysis in conjunction with our consolidated financial statements and the related notes thereto included in Item 1 of Part I. Unless otherwise indicated, all references to "we," "us," "our," "the Company," or similar terms refer to EHI, together with its subsidiaries. In this Quarterly Report on Form 10-Q, the Company and its management discuss and make statements based on currently available information regarding their intentions, beliefs, current expectations, and projections of, among other things, the Company's future performance, economic or market conditions, including current or future levels of inflation, potential implications of increased tariffs, changes in interest rates, labor market expectations, catastrophic events or geo-political conditions, legislative or regulatory actions or court decisions, business growth, retention rates, loss costs, claim trends and the impact of key business initiatives, future technologies and planned investments. Certain of these statements may constitute "forward-looking" statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts and are often identified by words such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "target," "project," "intend," "believe," "estimate," "predict," "potential," "pro forma," "seek," "likely," or "continue," or other comparable terminology and their negatives. The Company and its management caution investors that such forward-looking statements are not guarantees of future performance. Risks and uncertainties are inherent in the Company’s future performance. Factors that could cause the Company's actual results to differ materially from those indicated by such forward-looking statements include, among other things, those discussed or identified from time to time in the Company’s public filings with the SEC, including the risks detailed in the Company's Annual Reports on Form 10-K and in the Company's Quarterly Reports on Form 10-Q. Except as required by applicable securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

General

We are a Nevada holding company. Through our insurance subsidiaries, we provide workers’ compensation insurance coverage to small and mid-sized businesses engaged in low-to-medium hazard industries. Workers’ compensation insurance is provided under a statutory system wherein most employers are required to provide coverage for their employees’ medical, disability, vocational rehabilitation, and/or death benefit costs for work-related injuries or illnesses. We provide workers’ compensation insurance throughout most of the United States, with a concentration in California, where 46% of our trailing twelve month gross written premiums are generated. Our revenues primarily consist of net premiums earned, net investment income, and net realized and unrealized gains and losses on investments.

The insurance industry is highly competitive, and there is significant competition in the national workers’ compensation industry that is based on price and quality of services. We compete with other specialty workers’ compensation carriers, state agencies, multi-line insurance companies, professional employer organizations, self-insurance funds, and state insurance pools.

We target small to mid-sized businesses, as we believe that this market is traditionally characterized by higher profitability and stronger persistency when compared to the U.S. workers’ compensation insurance industry in general. We believe we can price our policies at levels that are competitive and profitable over the long-term given our expertise in underwriting and claims handling in this market segment. Our underwriting approach is to consistently underwrite small to mid-sized business accounts at appropriate and competitive prices without sacrificing long-term profitability and stability for short-term revenue growth.

We pursue profitable growth opportunities by focusing on disciplined underwriting and claims management, utilizing medical provider networks designed to produce superior medical and indemnity outcomes, establishing and maintaining strong, long-term relationships with traditional and specialty insurance agencies, developing important alternative distribution channels, and offering workers' compensation solutions directly to customers.

We believe we have a cost-effective and scalable information technology infrastructure that complements our geographic reach and business model. We continue to invest in technology to automate business processes and further develop our data analytic capabilities, which we believe will enable us to reduce our operating costs over the long-term and set a foundation for our future needs. We believe our technology saves our insurance agents and brokers, and our policyholders, considerable time and maintains our competitiveness in our target markets.

We continue to execute ongoing business initiatives focused on achieving process excellence and efficiency, as well as, delivering self-service options to policyholders, agents, and injured workers. Additionally, we are actively pursuing strategies to diversify our geographic and economic sector risk exposures, expand our risk appetite, and broaden our product offerings.

Overview

Summary Financial Results

Our net (loss) income was $(8.3) million and $34.2 million for the three and nine months ended September 30, 2025, respectively, compared to $30.3 million and $90.3 million for the corresponding periods of 2024. The key factors that affected our financial performance during the three and nine months ended September 30, 2025, compared to the same periods of 2024, included:

  • Gross premiums written increased 1.5% and decreased 0.1%;
  • Net premiums earned increased 2.9% and 2.5%;
  • Net investment income decreased 1.9% and increased 6.2%;
  • Net realized and unrealized gains on investments of $21.2 million and $29.3 million compared to $10.9 million and $24.5 million;
  • Losses and LAE increased 58.5% and 30.4%;
  • Commission expense decreased 10.9% and 6.2%;
  • Underwriting expenses decreased 9.6% and 4.8%;
  • Underwriting (loss) income of $(57.1) million and $(71.8) million compared to $(0.7) million and $7.4 million; and
  • Other non-recurring expenses of $1.1 million.

Three and Nine Months Ended September 30, 2025

Our 2025 underwriting results demonstrate moderate growth in net premiums earned, accompanied by reductions in both commission expense and underwriting expenses. These improvements were offset by higher losses and LAE compared to the same periods of 2024. Our 2025 investment results were strong, driven by solid net investment income and favorable net realized and unrealized gains.

Three and Nine Months Ended September 30, 2024

Our 2024 underwriting results reflect moderate increases in net premiums earned, compared to the same periods of 2023, due to higher new and renewal business premiums, as well as favorable prior year loss reserve development and lower underwriting expenses. Our 2024 investment results benefited from strong and steady net investment income and moderate net realized and unrealized gains.

Our consolidated financial results of operations for the three and nine months ended September 30, 2025 and 2024 are as follows:

(in millions)

Three Months Ended September 30, 2025 2024 Nine Months Ended September 30, 2025 2024
Gross premiums written $183.9 $181.2 $599.3 $599.9
Net premiums written $182.4 $179.6 $594.2 $594.8
Net premiums earned $192.1 $186.6 $573.4 $559.3
Net investment income 26.1 26.6 85.3 80.3
Net realized and unrealized gains on investments 21.2 10.9 29.3 24.5
Other (loss) income (0.1) (0.1) 0.2 —
Total revenues 239.3 224.0 688.2 664.1
Underwriting expenses:
Losses and LAE 186.6 117.7 447.4 343.0
Commission expense 23.0 25.8 72.1 76.9
Underwriting expenses 39.6 43.8 125.7 132.0
Non-underwriting expenses:
Interest and financing expenses 0.2 — 0.3 0.1
Other non-recurring expenses 1.1 — 1.1 —
Total expenses 250.5 187.3 646.6 552.0
Net (loss) income before income taxes (11.2) 36.7 41.6 112.1
Income tax (benefit) expense (2.9) 6.4 7.4 21.8
Net (loss) income $(8.3) $30.3 $34.2 $90.3

31

I. Review of Underwriting Results

Underwriting income or loss is determined by deducting losses and LAE, commission expense, and underwriting expenses from net premiums earned. Our underwriting results for the three and nine months ended September 30, 2025 and 2024 are as follows:

(in millions)

Three Months Ended September 30, 2025 2024 Nine Months Ended September 30, 2025 2024
Gross premiums written $183.9 $181.2 $599.3 $599.9
Net premiums written $182.4 $179.6 $594.2 $594.8
Net premiums earned $192.1 $186.6 $573.4 $559.3
Losses and LAE 186.6 117.7 447.4 343.0
Commission expense 23.0 25.8 72.1 76.9
Underwriting expenses 39.6 43.8 125.7 132.0
Total underwriting expenses 249.2 187.3 645.2 551.9
Underwriting (loss) income $(57.1) $(0.7) $(71.8) $7.4
Total impact of the LPT (1.3) (1.5) (4.6) (5.8)
Underwriting (loss) income excluding LPT(1) $(58.4) $(2.2) $(76.4) $1.6
Loss and LAE ratio 97.1% 63.1% 78.0% 61.3%
Commission expense ratio 12.0 13.8 12.6 13.8
Underwriting expense ratio 20.6 23.5 21.9 23.6
Combined ratio 129.7% 100.4% 112.5% 98.7%
Total impact of the LPT 0.7% 0.8% 0.8% 1.0%
Combined ratio excluding LPT(1) 130.4% 101.2% 113.3% 99.7%

(1) The LPT Agreement is a non-recurring transaction that no longer provides us with any ongoing cash benefits. We provide our underwriting income and combined ratios excluding the effects of the LPT because we believe that these measures are useful in providing investors, analysts and other interested parties a meaningful understanding of our ongoing underwriting performance and provides them with a consistent basis for comparison with other companies in our industry. In addition, we believe that these non-GAAP measures, as presented, are helpful to our management in identifying trends in our performance because the LPT has limited significance to our current and ongoing operations.

Gross Premiums Written

Gross premiums written were $183.9 million and $599.3 million for the three and nine months ended September 30, 2025, respectively, compared to $181.2 million and $599.9 million for the corresponding periods of 2024. For the three months ended September 30, 2025, the increase in gross premiums written was largely driven by growth in renewal business premiums. For the nine months ended September 30, 2025, gross premiums written were flat, as increases in renewal business premiums were offset by decreases in new business premiums. Nonetheless, we closed another quarter with a record number of policies in-force. Total in-force policies at September 30, 2025 were 135,414 compared to 134,421 in-force policies at June 30, 2025, and 130,767 in-force policies at December 31, 2024.

Net Premiums Written

Net premiums written are gross premiums written less reinsurance premiums ceded. For each of the periods presented, the reinsurance premiums ceded related to our annual reinsurance program as further described herein.

Net premiums written were $182.4 million and $594.2 million for the three and nine months ended September 30, 2025, respectively, compared to $179.6 million and $594.8 million for the corresponding periods of 2024. Reinsurance premiums ceded were $1.5 million and $5.1 million for the three and nine months ended September 30, 2025, respectively, compared to $1.6 million and $5.1 million for the corresponding periods of 2024.

Net Premiums Earned

Net premiums earned are primarily a function of the amount and timing of net premiums previously written.

Net premiums earned were $192.1 million and $573.4 million for the three and nine months ended September 30, 2025, respectively, compared to $186.6 million and $559.3 million for the corresponding periods of 2024.

Losses and LAE, Commission Expenses, and Underwriting Expenses

The following table presents our calendar year combined ratios.

Three Months Ended September 30, 2025 2024 Nine Months Ended September 30, 2025 2024
Loss and LAE ratio excluding LPT 97.8% 63.9% 78.8% 62.3%
Loss and LAE ratio - LPT (0.7) (0.8) (0.8) (1.0)
Commission expense ratio 12.0 13.8 12.6 13.8
Underwriting expense ratio 20.6 23.5 21.9 23.6
Combined ratio 129.7% 100.4% 112.5% 98.7%
Combined ratio excluding LPT 130.4% 101.2% 113.3% 99.7%

Losses and LAE

Losses and LAE represents our largest expense item and includes claim payments made, amortization of the Deferred Gain, Contingent Commission adjustments, estimates for future claim payments and changes in those estimates for current and prior accident years, and costs associated with investigating, defending, and adjusting claims. The accuracy of our financial reporting depends in large part on determining our losses and LAE reserves, which are inherently uncertain as they are estimates of the ultimate cost of individual claims based on actuarial estimation techniques. We believe that our loss estimates are adequate; however, ultimate losses will not be known with any certainty for many years.

We analyze our loss and LAE ratios on both a calendar year and accident year basis.

The calendar year loss and LAE ratio is calculated by dividing the losses and LAE recorded during the calendar year, regardless of when the underlying insured event occurred, by the net premiums earned during that calendar year. The calendar year loss and LAE ratio reflects changes made during the calendar year in reserves for losses and LAE established for insured events occurring in the current and prior years. The calendar year loss and LAE ratio for a particular year will not change in future periods.

The accident year loss and LAE ratio is calculated by dividing cumulative losses and LAE that occurred during a particular year by the net premiums earned for that year. The accident year loss and LAE ratio for a particular year can decrease or increase when recalculated in subsequent periods as the reserves established for insured events occurring during that year fluctuate. Our current accident year loss and LAE ratios continue to reflect the impact of key business initiatives, including: an emphasis on accelerated settlements of open claims; further diversifying risk exposure across geographic markets, when appropriate; and leveraging data-driven strategies to target, underwrite, and price profitable classes of business across all of our markets.

Our calendar year loss and LAE ratio is analyzed to measure profitability in a particular year and to evaluate the adequacy of premium rates charged in a particular year to cover expected losses and LAE from all periods, including development (whether favorable or adverse) of reserves established in prior periods. In contrast, our accident year loss and LAE ratios are analyzed to evaluate underwriting performance and the adequacy of the premium rates charged in a particular year in relation to ultimate losses and LAE from insured events occurring during that year. The loss and LAE ratios provided in this report are on a calendar year basis, except where they are expressly identified as accident year loss and LAE ratios.

The table below reflects current and prior accident year loss and LAE reserve adjustments, the impact of the LPT, and the resulting impact to our loss ratio.

(dollars in millions)

Three Months Ended September 30, 2025 2024 Nine Months Ended September 30, 2025 2024
Current accident year losses and LAE - excluding LPT $150.1 $119.3 $412.6 $358.1
Prior accident year adverse (favorable) loss reserve development, net 37.8 (0.1) 39.4 (9.3)
Impact of LPT (1.3) (1.5) (4.6) (5.8)
Calendar year losses and LAE $186.6 $117.7 $447.4 $343.0
Current accident year loss and LAE ratio - excluding LPT 78.1% 63.9% 72.0% 64.0%
Calendar year loss and LAE ratio - excluding LPT 97.8% 63.9% 78.8% 62.3%
Calendar year loss and LAE ratio 97.1% 63.1% 78.0% 61.3%

The increase in our calendar year losses and LAE during the three months ended September 30, 2025, as compared to the same period of 2024, was primarily due to a higher current accident year loss and LAE estimate and reserve strengthening related to prior accident years. During the three months ended September 30, 2025, we increased the current accident year loss and LAE ratio to 72.0%, a three point increase from the year-to-date loss and LAE ratio of 69.0% at June 30, 2025. The increase was attributable to increased cumulative trauma (CT) claim frequency in California. Incurred losses and LAE for the three months ended September 30, 2025 include a cumulative adjustment of $11.4 million to year-to-date incurred losses and LAE at June 30, 2025 to reflect the three point increase to the current accident year loss and LAE ratio.

During the three months ended September 30, 2025, we increased prior accident year loss and LAE estimates for our voluntary business by $38.2 million, with the reserve strengthening related primarily to accident years 2023 and 2024 being partially offset by net favorable development of loss and LAE estimates for accident years 2021 and prior. The increase in loss and LAE estimates for accident years 2023 and 2024 was due to the increased CT claim frequency in California and conservative modifications in our reserving approach across our complete book of business.

The increase in our calendar year losses and LAE during the nine months ended September 30, 2025, as compared to the same period of 2024, was due to a higher current accident year loss and LAE ratio, 72.0% versus 64.0%, respectively, and net reserve strengthening of prior accident year loss and LAE estimates described above.

Prior accident year adverse loss reserve development during the three months ended September 30, 2025 included $0.4 million of net favorable loss reserve development on our assigned risk business. Prior accident year favorable loss reserve development on our assigned risk business totaled $0.1 million during the three months ended September 30, 2024.

Prior accident year adverse loss reserve development totaled $39.4 million during the nine months ended September 30, 2025, which included $38.9 million net adverse loss reserve development on our voluntary risk business and $0.5 million net adverse loss reserve development on our assigned risk business. Prior accident year favorable loss reserve development on our voluntary risk business totaled $9.3 million during the nine months ended September 30, 2024.

The table below reflects the impact of the LPT on Losses and LAE, which are recorded as a reduction to Losses and LAE incurred on our Consolidated Statements of Comprehensive Income (Loss).

(in millions)

Three Months Ended September 30, 2025 2024 Nine Months Ended September 30, 2025 2024
Amortization of the Deferred Gain - losses $1.3 $1.5 $4.6 $4.6
Amortization of the Deferred Gain - Contingent Commission — — — 0.8
Contingent Commission adjustments — — — 0.4
Total impact of the LPT $1.3 $1.5 $4.6 $5.8

Commission Expense

Commission expense includes direct commissions to our agents and brokers, including our partnerships and alliances, for the premiums that they produce for us, as well as agency incentive payments, other marketing costs, and fees.

We refined the presentation of certain expenses associated with our involuntary premium during 2024. This revision, which was immaterial, reduced both our third quarter 2024 and the first nine months of 2024 commission expense and commission expense ratio by approximately $0.6 million and $1.8 million and 0.3 percentage points, respectively, and increased our respective underwriting expenses and underwriting expense ratio by the same amounts. These revisions had no effect on our total expenses or net income.

Our commission expense ratio was 12.0% and 12.6% for the three and nine months ended September 30, 2025, respectively, compared to 13.8% for each of the corresponding periods of 2024, and our commission expense was $23.0 million and $72.1 million for the three and nine months ended September 30, 2025, respectively, compared to $25.8 million and $76.9 million for the corresponding periods of 2024. The decrease in our commission expense for the three and nine months ended September 30, 2025, was primarily related to lower agency incentive accruals, which are specific to individual contracts and vary with agency targets, and a release of commissions payable associated with non-performing policies sent to collections.

The reduction in our commission expense ratio for the three months ended September 30, 2025 was primarily related to an increase in the proportion of renewal premiums, which are typically subject to a lower commission rate, and lower agency incentive accruals. The reduction in our commission expense ratio for the nine months ended September 30, 2025 was primarily related to an increase in the proportion of renewal premiums, which are subject to a lower commission rate, a release of commissions payable associated with non-performing policies sent to collections, and lower agency incentive accruals.

Underwriting Expenses

Underwriting expenses represent those costs required to run the business, including costs incurred to underwrite and maintain the insurance policies we issue, excluding commissions. Variable underwriting expenses, such as premium taxes, policyholder dividends, and other expenses that vary directly with the production of new or renewal business, are recognized as the associated written premiums are earned. Fixed underwriting expenses, such as the operating expenses of EHI and its subsidiaries, do not vary directly with the production of new or renewal business and are recognized as incurred.

Our underwriting expense ratio was 20.6% and 21.9% for the three and nine months ended September 30, 2025, respectively, compared to 23.5% and 23.6% for the corresponding periods of 2024, and our underwriting expenses were $39.6 million and $125.7 million for the three and nine months ended September 30, 2025, respectively, compared to $43.8 million and $132.0 million for the corresponding periods of 2024. The reduction in our underwriting expense ratio for the three and nine months ended September 30, 2025 was driven by our disciplined focus on expense reduction.

The decrease in underwriting expenses for the three months ended September 30, 2025, was primarily the result of decreases in (i) compensation-related expenses of $4.0 million, of which $2.0 million related to incentives; (ii) policyholder dividends of $0.8 million; and (iii) net CECL provision on premiums receivable of $0.5 million. These decreases were partially offset by lower internal AO and other expense allocations of $2.0 million, each compared to the same period of 2024.

The decrease in underwriting expenses for the nine months ended September 30, 2025, was primarily the result of decreases in (i) compensation-related expenses of $7.9 million, of which $5.3 million related to incentives; (ii) depreciation and amortization of $2.7 million; and (iii) policyholder dividends of $1.7 million. These decreases were partially offset by lower internal AO and other expense allocations of $7.4 million, each compared to the same period of 2024.

II. Review of Non-Underwriting Results

Net Investment Income and Net Realized and Unrealized Gains and Losses on Investments

We invest in fixed maturity securities, equity securities, other invested assets, short-term investments, and cash equivalents. Net investment income includes interest and dividends earned on our invested assets and amortization of premiums and discounts on our fixed maturity securities, less bank service charges and custodial and portfolio management fees.

Net investment income decreased 1.9% and increased 6.2% during the three and nine months ended September 30, 2025, respectively, compared to the same periods of 2024. The decrease for the three months ended September 30, 2025 was due to lower invested balances, along with lower yields on cash equivalents and short-term investments throughout the quarter. The increase for the nine months ended September 30, 2025 was primarily the result of returns from our investments in private equity limited partnerships, along with higher book yields on our fixed maturity securities.

Realized and unrealized gains and losses on our investments are reported separately from our net investment income. Realized gains and losses on investments include the gain or loss on a security at the time of sale compared to its original or adjusted cost (equity securities) or amortized cost (fixed maturity securities). Realized losses are also recognized for adverse changes in our CECL allowance or when securities are written down because of an other-than-temporary impairment. Changes in the fair value of equity securities and other invested assets are also included in Net realized and unrealized gains on investments on our Consolidated Statements of Comprehensive Income (Loss).

Net realized and unrealized gains on investments were $21.2 million and $29.3 million for the three and nine months ended September 30, 2025, respectively, compared to $10.9 million and $24.5 million for the corresponding periods of 2024. The Net realized and unrealized gains on investments for the three months ended September 30, 2025 and 2024 included $23.7 million and $12.8 million of net realized and unrealized gains on equity securities and other investments, respectively, partially offset by $2.5 million and $1.9 million of net realized losses on fixed maturity securities, respectively. The Net realized and unrealized gains on investments for the nine months ended September 30, 2025 and 2024 included $32.8 million and $30.8 million of net realized and unrealized gains on equity securities and other investments, respectively, partially offset by $3.5 million and $6.3 million of net realized losses on fixed maturity securities, respectively.

The net investment gains on our equity securities during the three and nine months ended September 30, 2025 were largely consistent with the performance of the U.S. equity markets. The net investment gains on our other investments during the three months ended September 30, 2025 resulted primarily from an increase in the underlying value of the private equity limited partnership interests we own. The net investment gains on our other investments during the nine months ended September 30, 2025 resulted primarily from an increase in the underlying value of the private equity limited partnership interests we own partially offset by a reduction in net asset value due to distributed investment returns from those same investments. The net realized investment losses on our fixed maturity securities during the three and nine months ended September 30, 2025 were primarily the result of sales associated with the rebalancing of our fixed maturity investment portfolio partially offset in each period by a $0.5 million decrease in our allowance for CECL.

The Net investment gains and losses on our equity securities during the three and nine months ended September 30, 2024 were largely consistent with the performance of the U.S. equity markets. The net investment gains on our other investments during the nine months ended September 30, 2024 resulted primarily from an increase in the underlying value of the private equity limited partnership interests we own. The net realized investment losses on our fixed maturity securities during the three and nine months ended September 30, 2024 were primarily the result of sales associated with the rebalancing of our fixed maturity investment portfolio partially offset by a $0.5 million and $1.3 million decrease in our allowance for CECL, respectively.

Additional information regarding our Investments is set forth under “—Liquidity and Capital Resources—Investments.”

Other Income (Loss)

Other income (loss) consists of net gains and losses on fixed assets, non-investment interest, and other miscellaneous income and expense items.

Interest and Financing Expenses

Interest and financing expenses include fees and interest associated with our credit facilities, finance lease interest, and other financing fees.

Interest and financing expenses were $0.2 million and $0.3 million for the three and nine months ended September 30, 2025, respectively, compared to less than $0.1 million and $0.1 million for the corresponding periods of 2024.

Other non-recurring expenses

Other non-recurring expenses were $1.1 million for each of the three and nine months ended September 30, 2025. During the three months ended September 30, 2025, we recorded charges of $1.3 million of employee severance costs in connection with a third quarter 2025 reorganization, which was undertaken to better align our resources with our business objectives. These charges were offset by other miscellaneous one-time items.

Income Tax (Benefit) Expense

Income tax (benefit) expense was $(2.9) million and $7.4 million for the three and nine months ended September 30, 2025, respectively, compared to $6.4 million and $21.8 million for the corresponding periods of 2024. The effective tax rates were 25.9% and 17.8% for the three and nine months ended September 30, 2025, respectively, compared to 17.4% and 19.4% for the corresponding periods of 2024. The effective rates during each of the periods presented deviate favorably from the statutory rate of 21.0% due to, in part, income tax benefits and exclusions associated with tax-advantaged investment income, LPT adjustments, Deferred Gain amortization and related adjustments, and tax credits utilized.

Liquidity and Capital Resources

We believe that our total capital position remains strong and that the liquidity available to EHI and its subsidiaries remains adequate and will be sufficient for our financing needs in the next 12 months and in the longer-term period thereafter. As a result, we do not currently foresee a need to: (i) suspend dividends at either EHI or its insurance subsidiaries; (ii) forego repurchases of EHI's common stock; (iii) seek additional required capital; or (iv) seek any material non-investment asset sales, though we may decide to pursue those or other options if our financial circumstances change or if we deem it strategically advantageous to do so.

EHI Liquidity

EHI is a holding company and its ability to fund its operations is contingent upon its existing capital and the ability of its subsidiaries to pay it dividends. Any payments of dividends by our insurance subsidiaries are restricted by state insurance laws and regulations, including laws establishing minimum solvency and liquidity thresholds. EHI requires cash to pay dividends to its stockholders, repurchase its common stock, provide additional surplus to its insurance subsidiaries, and fund its operating expenses.

EHI's insurance subsidiaries’ ability to pay dividends and distributions is based on their reported capital, surplus, and dividends paid within the prior twelve months.

During the first quarter of 2025, EICN made a $14.0 million dividend payment to EGI, which in turn distributed that amount to EHI. As a result of that dividend payment, EICN cannot pay dividends for the remainder of 2025 without prior regulatory approval.

During the first quarter of 2025, ECIC made a $23.5 million dividend payment to EGI, which in turn distributed that amount to EHI. As a result of that dividend payment, ECIC cannot pay dividends for the remainder of 2025 without prior regulatory approval.

During the second quarter of 2025, EPIC made a $23.9 million dividend payment to EGI, which in turn distributed that amount to EHI. As a result of that dividend payment, EPIC cannot pay dividends for the remainder of 2025 without prior regulatory approval.

During the second quarter of 2025, EAC made a $23.6 million dividend payment to EGI, which in turn distributed that amount to EHI. As a result of that dividend payment, EAC cannot pay dividends for the remainder of 2025 without prior regulatory approval.

During the third quarter of 2025, CIC made a $5.9 million dividend payment to EGI, which in turn distributed that amount to EHI. As a result of that dividend payment, CIC cannot pay dividends for the remainder of 2025 without prior regulatory approval.

Total cash and investments at the holding company were $41.2 million at September 30, 2025, consisting of $9.4 million of cash and cash equivalents, $6.1 million of fixed maturity securities, and $25.7 million of equity securities.

On May 28, 2024, EHI entered into the Credit Agreement which provides for a $25.0 million, unsecured, three-year revolving credit facility and is guaranteed by EGI and CGI. Borrowings under the Credit Agreement may be used for working capital and general corporate purposes of EHI and its subsidiaries. Pursuant to the terms of the Credit Agreement, EHI has an option to request an increase of the credit available under the facility up to a maximum facility amount of $35.0 million, subject to the consent of the lender(s) and the satisfaction of certain conditions.

The interest rates applicable to loans under the Credit Agreement are generally based on, at EHI's option: (i) a base rate, defined as the higher of the Prime Rate, the Federal Funds Rate plus 1.25% and the Adjusted Term SOFR Rate for a one-month tenor plus 1.75%, or (ii) an Adjusted Term SOFR Rate, defined as the applicable Adjusted Term SOFR Rate plus 1.75%. Borrowings under the Credit Agreement may be used for working capital and general corporate purposes of EHI and its subsidiaries.

The Credit Agreement contains covenants that require EHI and its consolidated subsidiaries to maintain: (i) a minimum consolidated net worth, defined as EHI’s total stockholders’ equity excluding any accumulated other comprehensive income or loss, of no less than $800.0 million; and (ii) a debt to total capitalization ratio of no more than 35%, in each case as determined in accordance with the Credit Agreement. As of September 30, 2025, EHI has remained in compliance with all of the covenants associated with the Credit Agreement since its inception.

EHI had no borrowings under the Credit Agreement during the nine months ended September 30, 2025.

Operating Subsidiaries’ Liquidity

The primary sources of cash for our operating subsidiaries, which include our insurance and other operating subsidiaries, are premium collections, investment income, sales and maturities of investments, and reinsurance recoveries. The primary uses of cash for our operating subsidiaries are payments of losses and LAE, commission expense, underwriting expenses, ceded reinsurance, investment purchases and dividends paid to their parent.

Total cash and investments held by our operating subsidiaries was $2,505.5 million at September 30, 2025, consisting of $157.6 million of cash and cash equivalents, and restricted cash, $1,973.4 million of fixed maturity securities, $264.6 million of equity securities, $104.3 million of other invested assets, and $5.6 million of short-term investments. Sources of immediate and unencumbered liquidity at our operating subsidiaries as of September 30, 2025 consisted of $157.4 million of cash and cash equivalents, $257.1 million of publicly traded equity securities whose proceeds are available within two business days, and $721.8 million of highly liquid fixed maturity securities whose proceeds are also available within two business days. We believe that our subsidiaries’ liquidity needs over the next 12 months and for the longer-term period thereafter will be met with cash from operations, investment income, and maturing investments.

Each of our insurance subsidiaries are members of the FHLB. Membership allows our subsidiaries access to collateralized advances, which may be used to support and enhance liquidity management. The amount of advances that may be taken is dependent on our statutory admitted assets on a per company basis.

FHLB membership also allows our insurance subsidiaries access to standby Letter of Credit Agreements. Letter of Credit Agreements we currently have in effect will expire March 31, 2026 and must be fully secured with eligible collateral at all times (See Note 10).

Various state laws and regulations require us to hold investment securities or letters of credit on deposit with certain states in which we do business. Securities having a fair value of $575.9 million and $630.9 million were on deposit at September 30, 2025 and December 31, 2024, respectively. These laws and regulations govern both the amount and types of investment securities that are eligible for deposit. Additionally, standby letters of credit from the FHLB have been issued in lieu of $170.0 million of securities on deposit at both September 30, 2025 and December 31, 2024.

We purchase reinsurance annually to protect us against the costs of severe claims and certain catastrophic events. On July 1, 2025, we entered into a new reinsurance program that is effective through June 30, 2026. The reinsurance program consists of one treaty covering excess of loss and catastrophic loss events in four layers of coverage, which includes a 10% co-participation share within each layer of coverage retained by us. Our reinsurance coverage is $190.0 million ($171.0 million net of our co-participation) in excess of our $10.0 million retention on a per occurrence basis, including a maximum any one life limit of $20.0 million, subject to certain exclusions. We believe that our reinsurance program currently meets our needs.

Certain reinsurance contracts require funds owned by us to be held in trust for the benefit of the ceding reinsurer to secure the outstanding liabilities we have assumed. The fair value of fixed maturity securities held in trust for the benefit of our ceding reinsurers was $3.1 million and $3.0 million at September 30, 2025 and December 31, 2024, respectively.

Sources of Liquidity

We monitor the cash flows of each of our subsidiaries individually, as well as collectively as a consolidated group. We use trend and variance analyses to project future cash needs, making adjustments to our cash forecasts as appropriate.

The table below shows our net cash flows:

(in millions)

Cash, cash equivalents, and restricted cash provided by (used in): Nine Months Ended 2025 2024
Operating activities $44.0 $63.3
Investing activities 167.4 (89.7)
Financing activities (112.9) (56.7)
Increase (decrease) in cash, cash equivalents, and restricted cash $98.5 $(83.1)

For additional information regarding our cash flows, see Item 1, Consolidated Statements of Cash Flows.

Operating Activities

Net cash provided by operating activities for the nine months ended September 30, 2025, included net premiums received of $584.3 million and investment income received of $85.2 million. The cash provided by these operating activities were partially offset by net claims payments of $417.4 million, underwriting expenses paid of $120.7 million, commissions paid of $74.4 million, other non-recurring expenses paid of $1.1 million, and federal income taxes paid of $11.6 million.

Net cash provided by operating activities for the nine months ended September 30, 2024, included net premiums received of $575.4 million, investment income received of $79.8 million, and cash received of $14.6 million for the Contingent Commission. The cash provided by these operating activities were largely offset by net claims payments of $381.7 million, underwriting and general and administrative expenses paid of $124.1 million, commissions paid of $77.6 million, and federal income taxes paid of $23.0 million.

Investing Activities

Net cash provided by investing activities for the nine months ended September 30, 2025, related primarily to returns from our investments, investment sales, maturities, and redemptions whose proceeds were used to fund claims payments, underwriting expenses, stockholder dividend payments, and common stock repurchases. Those investing cash inflows were partially offset by investments of premiums received and the reinvestment of funds from investment sales, maturities, redemptions and interest income.

Net cash used in investing activities for the nine months ended September 30, 2024, related primarily to investment of premiums received, the receipt of Contingent Commission, and the reinvestment of funds from investment sales, maturities, redemptions, and interest income. The cash used in these investment activities was partially offset by investment sales, maturities, and redemptions whose proceeds were used to fund claims payments, underwriting expenses, stockholder dividend payments, and common stock repurchases.

Financing Activities

Net cash used in financing activities for each of the nine months ended September 30, 2025 and 2024, related primarily to stockholder dividend payments and common stock repurchases.

Dividends

We paid $22.8 million in dividends to our stockholders and eligible equity plan award holders for each of the nine months ended September 30, 2025 and 2024. The declaration and payment of future dividends to our stockholders, including any special dividends, will be at the discretion of our Board of Directors (Board) and will depend upon many factors including our financial position, capital requirements of our operating subsidiaries, legal and regulatory requirements, and any other factors that our Board deems relevant. On October 29, 2025, the Board declared a quarterly dividend per share of $0.32, which is payable November 26, 2025 to stockholders of record on November 12, 2025.

Stock Repurchases

We repurchased 1,049,401 shares of our common stock for $45.2 million during the three months ended September 30, 2025 and we repurchased 1,937,502 shares of our common stock for $88.6 million during the nine months ended September 30, 2025. Future repurchases of our common stock will be at the discretion of our Board and will depend upon many factors, including our financial position, capital requirements of our operating subsidiaries, general business and socioeconomic conditions, legal, tax, regulatory, and/or contractual restrictions, and any other factors that our Board deems relevant.

Capital Resources

As of September 30, 2025, the capital resources available to us consisted of $1,039.2 million of stockholders’ equity and the $89.4 million Deferred Gain.

Contractual Obligations and Commitments

Other than operating expenses, our current and long-term cash requirements include the following contractual obligations and commitments as of September 30, 2025:

Leases

We have entered into lease arrangements for certain equipment and facilities. As of September 30, 2025, we had lease payment obligations totaling $4.7 million, of which $0.8 million is payable within 12 months.

Other Purchase Obligations

We have other purchase obligations that primarily consist of non-cancellable obligations to acquire capital assets, commitments for information technology and related services, software acquisition and license commitments, and other legally binding agreements to purchase services that are to be used in our operations. As of September 30, 2025, we had other purchase obligations totaling $10.4 million, of which $5.1 million is payable within 12 months.

Unfunded Investment Commitments

As of September 30, 2025, we had private equity limited partnerships with unfunded investment commitments totaling $12.4 million that can be called at any time.

Unpaid Losses and LAE Expenses

We have developed unpaid losses and LAE expense payment patterns that are computed based on historical information. Our calculation of loss and LAE expense payments by period is subject to the same uncertainties associated with determining the level of reserves and to the additional uncertainties arising from the difficulty of predicting when claims (including claims that have not yet been reported to us) will be paid. Actual payments of losses and LAE by period will vary, perhaps materially, to the extent that current estimates of losses and LAE expense vary from actual ultimate claims amounts due to variations between expected and actual payment patterns. As of September 30, 2025, we had unpaid losses and LAE reserves totaling $1,822.5 million, of which $335.6 million is payable within 12 months.

The unpaid losses and LAE expense payment patterns are gross of reinsurance recoverables for unpaid losses. As of September 30, 2025, we had reinsurance recoverables on unpaid losses and LAE totaling $392.7 million, of which $29.3 million is currently expected to be received within 12 months.

Investments

Our investment portfolio is structured to support our need for: (i) optimizing our risk-adjusted total returns; (ii) providing adequate liquidity; (iii) facilitating financial strength and stability; and (iv) ensuring regulatory and legal compliance. These investments provide a steady source of income.

As of September 30, 2025, our investment portfolio consisted of 83% fixed maturity securities with a duration of 4.4, which is measured by their sensitivity to changes in interest rates. Our investment strategy balances consideration of duration, yield, and credit risk. Our investment guidelines require that the minimum weighted average quality of our fixed maturity securities portfolio be “A,” using ratings assigned by Standard & Poor’s (S&P) or an equivalent rating assigned by another nationally recognized statistical rating agency. Our fixed maturity portfolio had a weighted average quality of “A+” as of September 30, 2025.

Our investment portfolio also contains equity securities. We strive to limit the exposure to equity price risk associated with publicly traded equity securities by diversifying our holdings across several industry sectors. These equity securities had a fair value of $282.8 million at September 30, 2025, which represented 12% of our investment portfolio at that time. We also have a $7.5 million investment in FHLB stock which we record at cost. We receive periodic dividends from the FHLB for this investment, when declared, which can vary from period to period.

Our investment portfolio also contains certain other investments, which made up 4% of our investment portfolio at September 30, 2025, and include private equity limited partnerships. Our investments in private equity limited partnerships totaled $104.3 million at September 30, 2025 and are generally not redeemable by the investees and cannot be sold without prior approval of the general partner. These investments have a fund term of 3 to 12 years, subject to two or three one-year extensions at the general partner’s discretion. We periodically receive distributions of proceeds from dividends and interest from fund investments, as well as from any dispositions of fund investments, during the full course of the fund term. As of September 30, 2025, we had unfunded commitments to these private equity limited partnerships totaling $12.4 million.

We believe that our current asset allocation meets our strategy to preserve capital for claims and policy liabilities and to provide sufficient capital resources to support and grow our ongoing insurance operations.

The following table shows the estimated fair value, the percentage of the fair value to total invested assets, and the average ending book yield (which is calculated based on the amortized cost of the associated invested assets) as of September 30, 2025.

(in millions, except percentages)

Category Estimated Fair Value Percentage of Total Book Yield
U.S. Treasuries $68.4 3.0% 3.6%
States and municipalities 157.9 7.0 4.5
Corporate securities 710.3 31.3 4.4
Residential mortgage-backed securities 635.0 28.0 4.4
Commercial mortgage-backed securities 55.3 2.4 3.9
Asset-backed securities 188.4 8.3 5.2
Collateralized loan obligations 17.8 0.8 5.8
Foreign government securities 10.3 0.5 2.8
Other securities 136.1 6.0 7.2
Equity securities 282.8 12.5 2.7
Short-term investments 5.6 0.2 4.4
Total investments at fair value $2,267.9 100.0%
Weighted average book yield 4.6%

40

The following table shows the percentage of total estimated fair value of our fixed maturity securities as of September 30, 2025 by credit rating category, using the lower of the ratings assigned by Moody’s Investors Service or S&P.

Rating Percentage of Total Estimated Fair Value
“AAA” 9.8%
“AA” 43.2
“A” 28.3
“BBB” 10.6
Below Investment Grade 8.1
Total 100.0%

Investments that we currently own could be subject to default by the issuer. We regularly assess individual securities as part of our ongoing portfolio management, including the identification of credit-related losses. Our assessment includes reviewing the extent of declines in the fair value of investments below amortized cost, historical and projected financial performance and near-term prospects of the issuer, the outlook for industry sectors, credit rating, and macro-economic changes. We also make a determination as to whether it is not more likely than not that we will be required to sell the security before its fair value recovers to above cost, or maturity.

In addition to recognizing realized gains and losses upon the disposition of an investment security, we also record provisions and recoveries for changes in CECL allowance on AFS investments as realized gains and losses. As of September 30, 2025, we maintained a CECL allowance of $0.6 million on AFS investments. During the nine months ended September 30, 2025, we recognized a net $0.5 million decrease to our allowance for CECL on AFS investments. The remaining fixed maturity securities whose total fair value was less than amortized cost at September 30, 2025, were those in which we had no intent, need, or requirement to sell at an amount less than their amortized cost.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Critical Accounting Estimates

The unaudited interim consolidated financial statements included in this quarterly report include amounts based on the use of estimates and judgments of management for those transactions that are not yet complete. We believe that the estimates and judgments that were most critical to the preparation of the consolidated financial statements involved the reserves for losses and LAE and reinsurance recoverables. These estimates and judgments require the use of assumptions about matters that are highly uncertain and therefore are subject to change as facts and circumstances develop. Our accounting policies are discussed under "Critical Accounting Estimates" in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report.

Market risk

As filed, 8,719 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Market risk is the risk of potential economic loss principally arising from adverse changes in the fair value of financial instruments. The major components of market risk affecting us are credit risk, interest rate risk, and equity price risk.

Credit Risk

Our fixed maturity securities, equity securities, other invested assets, and cash and cash equivalents are exposed to credit risk, which we attempt to mitigate through issuer and industry diversification. Our investment guidelines include limitations on the minimum rating of fixed maturity securities and concentrations of a single issuer.

We also bear credit risk with respect to the reinsurers, which can be significant considering that some loss reserves remain outstanding for an extended period of time. We are required to pay losses even if a reinsurer refuses or fails to meet its obligations to us under the applicable reinsurance agreement(s). We continually monitor the financial condition and financial strength ratings of our reinsurers. Additionally, we bear credit risk with respect to premiums receivable, which is generally diversified due to the large number of entities comprising our policyholder base and their dispersion across many different industries and geographies.

Economic disruptions caused by ongoing financial market volatility, inflationary pressures, and heightened geo-political conditions, have impacted the credit risk associated with certain of our investment holdings. As of September 30, 2025, we maintained a $0.6 million allowance for CECL on our fixed maturity portfolio. See Note 5 to the consolidated financial statements.

Interest Rate Risk

Investments

Our fixed maturity securities are exposed to interest rate risk, which is the risk of a change in fair value resulting from changes in prevailing interest rates, which we manage through duration. Our fixed maturity investments (excluding cash and cash equivalents) had a duration of 4.4, which is measured by their sensitivity to changes in interest rates, at September 30, 2025. Our investment strategy balances consideration of duration, yield and credit risk. We continually monitor the changes in interest rates and their impact on our liquidity and ability to meet our obligations.

Sensitivity Analysis

The fair values or cash flows of our market sensitive investments are subject to potential losses in future earnings resulting from changes in interest rates and other market conditions. Our sensitivity analysis applies a hypothetical parallel shift in market rates and reflects what we believe are reasonably possible near-term changes in those rates (covering a period of time going forward up to one year from the date of the consolidated financial statements). Actual results may differ from the hypothetical change in market rates assumed in this disclosure. This sensitivity analysis does not reflect the results of any action that we may take to mitigate such hypothetical losses in fair value.

We use fair values to measure our potential loss in this model, which includes fixed maturity securities and short-term investments. For invested assets, we use modified duration modeling to calculate changes in fair values. Durations on invested assets are adjusted for call, put, and interest rate reset features. Invested asset portfolio durations are calculated on a market value weighted basis, excluding accrued investment income, using holdings as of September 30, 2025. The estimated changes in fair values on our fixed maturity securities and short-term investments, which had an aggregate value of $1,985.1 million as of September 30, 2025, based on specific changes in interest rates are as follows:

(in millions, except percentages)

Hypothetical Changes in Interest Rates Estimated Pre-tax Increase (Decrease) in Fair Value
300 basis point rise $(242.1) (12.2)%
200 basis point rise (163.7) (8.3)
100 basis point rise (82.2) (4.1)
50 basis point decline 41.2 2.1
100 basis point decline 81.2 4.1
200 basis point decline 159.0 8.0
300 basis point decline 235.1 11.8

The most significant assessment of the effects of hypothetical changes in interest rates on investment income would be based on GAAP guidance related to "Accounting for Nonrefundable Fees and Costs Associated with Originating or Acquiring Loans and Initial Direct Costs of Leases," which requires amortization adjustments for mortgage-backed securities. The rates at which the mortgages underlying mortgage-backed securities are prepaid, and therefore the average life of mortgage-backed securities, can vary depending on changes in interest rates (for example, mortgages tend to prepay faster and the average life of mortgage-backed securities falls when interest rates decline). Adjustments for changes in amortization are based on revised average life assumptions and would have an impact on investment income if a significant portion of our commercial and residential mortgage-backed securities were purchased at significant discounts or premiums to par value. As of September 30, 2025, the par value of our commercial and residential mortgage-backed securities holdings was $716.0 million, and the amortized cost was 101.0% of par value. The commercial and residential mortgage-backed securities portion of the portfolio totaled 30.4% of total investments as of September 30, 2025. Agency-backed residential mortgage pass-throughs represented 89.0% of the residential mortgage-backed securities portion of the portfolio as of September 30, 2025.

Equity Price Risk

Equity price risk is the risk of a decline in market value of the equity securities we hold in our investment portfolio. Adverse changes in the market prices of the equity securities we hold in our investment portfolio could result in decreases in the fair value of our total assets on our Consolidated Balance Sheets and in net realized and unrealized gains and losses on our Consolidated Statements of Comprehensive Income (Loss). Economic and market disruptions caused by geo-political conditions, inflationary pressures, and tariff uncertainty, have resulted in volatility in the fair value of our equity securities. We mitigate our exposure to equity price risk through dollar-cost averaging and by diversifying our equity holdings across several industry sectors.

The table below shows the sensitivity of our equity securities at fair value to price changes as of September 30, 2025:

(in millions)

Cost Fair Value 10% Fair Value Decrease Pre-tax Impact on Decrease in Total Equity Securities 10% Fair Value Increase Pre-tax Impact on Increase in Total Equity Securities
Equity securities $148.5 $282.8 $254.5 $(28.3) $311.1 $28.3

Effects of Inflation

In recent years, economic slowdowns, financial market volatility, monetary and fiscal policy measures, heightened geo-political tensions and fluctuations in interest rates have contributed to higher levels of inflation and may continue to lead to elevated levels of inflation in future periods.

Higher levels of inflation than we have anticipated could significantly impact our financial statements and results of operations. Our estimates for losses and LAE include assumptions about the timing of closure and future payment of claims and claims handling expenses, such as medical treatments and litigation costs. Inflation is also incorporated in our reserving process through projections supported by historical loss emergence, and particular consideration was given to medical and hospital inflation rates as these inflation rates have historically exceeded general inflation rates. To the extent that inflation causes these costs to increase above established reserves, we will be required to increase those reserves for losses and LAE, reducing our earnings in the period in which our assumptions are revised.

Higher levels of wage inflation can specifically impact the payrolls of our insureds, which is the basis for the premiums we charge, as well as the amount of future indemnity losses we may incur.

Higher levels of inflation could also adversely impact certain of our operating expenses and, in the case of wage inflation, could adversely impact our payroll expenses.

Elevated market interest rates in recent years, intended to aid in the suppression of inflation, continue to negatively impact the market value of our existing fixed maturity investments, despite our ability and intent to hold these investments to maturity. Higher interest rates, however, have also contributed to an increase in our net investment income.

Controls and procedures

As filed, 839 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

There have not been any changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 387 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We have disclosed in our Annual Report the most significant risk factors that can impact year-to-year comparisons and that may affect the future performance of our business. On a quarterly basis, we review these disclosures and update the risk factors, as appropriate. As of the date of this report, there have been no material changes to the risk factors contained in our Annual Report.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2025-07-01 to 2025-09-30$239.3mus-gaap:Revenues
Revenue9 months2025-01-01 to 2025-09-30$688.2mus-gaap:Revenues
Income tax3 months2025-07-01 to 2025-09-30−$2.9mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2025-01-01 to 2025-09-30$7.4mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2025-07-01 to 2025-09-30−$8.3mus-gaap:NetIncomeLoss
Net income9 months2025-01-01 to 2025-09-30$34.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2025-07-01 to 2025-09-30−$0.36us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2025-01-01 to 2025-09-30$1.42us-gaap:EarningsPerShareDiluted
Basic EPS3 months2025-07-01 to 2025-09-30−$0.36us-gaap:EarningsPerShareBasic
Basic EPS9 months2025-01-01 to 2025-09-30$1.43us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2025-07-01 to 2025-09-3023,351,319 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2025-01-01 to 2025-09-3024,027,153 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2025-01-01 to 2025-09-30$44.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Dividends paid9 months2025-01-01 to 2025-09-30$22.8mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases9 months2025-01-01 to 2025-09-30$88.7mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2025-09-30$166.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Total assetsAt period end2025-09-30$3.53bnus-gaap:Assets
Total liabilitiesAt period end2025-09-30$2.49bnus-gaap:Liabilities
Shareholders' equityAt period end2025-09-30$1.04bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001379041-25-000146. Last ingested by Listed: Nov 6, 2026, 05:30 ET. Listed shows no prices and gives no investment advice.